Kenneth Man

Lecturer @UCL @School_Pharmacy | CStat, FHEA, FRSPH | #RxEpi | #ADHD | Exploring the world with data | Prenatal, Children & Mental health | Views are my own

[Kenneth Man @KennethKCMan]

Honored with the Kramer-Pollnow Prize by @eunethydis! A heartfelt thank you to the organisation and to the brilliant minds in the field who inspire me every day. Grateful for this incredible recognition.
#KramerPollnowPrize #ADHD

[Nana C @Nana_UbonphanC]

Our study using data from the UK CPRD Aurum published in @CIDJournal shows that metformin use within 90 days of COVID-19 diagnosis reduces post-COVID risk in individuals with overweight/obesity.

📮Read more: https://t.co/eXxp6ohpv7

@ChengshengJ @LiWeiUCL @KennethKCMan

[Prof Ian Wong @Prof_IanWong]

"Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan", has been published by our international team! Read https://t.co/rPoLEEMVtr

[Prof Ian Wong @Prof_IanWong]

Our multinational network cohort study shows that extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the subside in risk for most complications over the medium- and long-term. https://t.co/MLjAWafbmg

[Kenneth Man @KennethKCMan]

🌍 Exciting PhD studentship at UCL School of Pharmacy!

Join the GENESIS project, a global collaboration using real-world data to advance mental health & maternal-child health research.

#PhD #Epidemiology #RegulatoryScience

🔗 https://t.co/MwtdNfWZk7

[The Pharmaceutical Journal @PJOnline_News]

The fifth and final member of our OPERA 2025 shortlist, @wallis_lau, was lauded by judges for her research’s influence on prescribing recommendations, ensuring safer anticoagulant use. Read more here: https://t.co/Ip5oIEetWC
The overall winner will be announced on 30 June 2025 🏆

[Hao Luo @HaoLuo_UW]

Our latest multinational study on trends in survival after #Dementia diagnosis has just been published with @SpringerNature in @CommsMedicine
Read here: https://t.co/B1LWgZI8Cf
@Ian_HKU @ChuiCeline @KennethKCMan @Knappem @GloW_hk

[The BMJ @bmj_latest]

The findings of this new study do not support a direct effect of gabapentinoid treatment on self-harm but underscore the necessity for close patient monitoring of self-harm throughout the gabapentinoid treatment journey
@KennethKCMan
https://t.co/oJgIipCBKS

[The BMJ @bmj_latest]

Treatment with gabapentinoids isn't directly associated with an increased risk of self-harm, finds this study.

However, rates of self-harm were higher before and shortly after treatment, highlighting the need for close monitoring of patients @KennethKCMan
https://t.co/oJgIipCBKS

[Kenneth Man @KennethKCMan]

New in @bmj_latest:
Gabapentinoid treatment not directly linked to increased self-harm risk.
Risk is highest before and after treatment—not during.
Close monitoring needed across the full treatment journey.

Read more: https://t.co/8PBMX2d1w1

[TIMESPAN @TIMESPAN_H2020]

🧠 #TIMESPAN is transforming #ADHD research. By uniting global data, we explore ADHD's impact on cardiometabolic conditions, capture treatment variations, and drive better outcomes worldwide. #ADHDResearch #GlobalHealth
➡ Full blog post: https://t.co/IbEGbRrVYT

[Alvin Richards-Belle @Alvin_R_B]

🚨 'Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation' published in @PLOSMedicine https://t.co/aFt3noMmwz

[Kenneth Man @KennethKCMan]

PhD Opportunity @UCL 🌍
Join our global collaboration with SKKU & partners, tackling key health challenges in mental health & maternal-child health using real-world data!
💡 Open to passionate candidates in epidemiology, stats, pharmacy & more!

@FindAPhD: https://t.co/mhYcdGAyJw

[Alvin Richards-Belle @Alvin_R_B]

🚨 'Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000–2019: 20-year investigation of who receives treatment, with which agents and at what doses' now published in @TheBJPsych https://t.co/4KsMVjjYaF

[JAMA Internal Medicine @JAMAInternalMed]

Metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1RA. https://t.co/JMxHHQmh7y

[Kenneth Man @KennethKCMan]

A very nice study by @BoheeLEE4 and @chloebloom using multiple study designs (self-controlled case series & cohort analysis) showed consistent results: metformin lowered asthma attack risk by ~30%, with GLP-1RA adding 40%. A robust approach to observational data!

[Kenneth Man @KennethKCMan]

Great study lead by @fredho42 looked into factors contributing to the association between deprivation and infant death. Targeting moderating factors may mitigate some the effects but will not stem the rise in infant mortality. #heathinequalities

https://t.co/WoQq5GzJRW

[Kenneth Man @KennethKCMan]

@2011YJ Thanks 😁

[Kenneth Man @KennethKCMan]

I was an ad-hoc reviewer in June 2023 and then was invited to be an ERC core member in Feb 2024.
Happy to take one step further as ERC chair for CPRD.

[Kenneth Man @KennethKCMan]

https://t.co/kAjSGU8knr

@Ian_HKU @HaoLuo429 @J_F_Hayes @wallis_lau @ChuiCeline @slseager78

[Kenneth Man @KennethKCMan]

Our new @OHDSI study in Lancet Psychiatry found that the prescribing rates of anxiolytics during the COVID-19 pandemic were persistently elevated, underscore the importance of enhanced mental health support and regular review of psychotropic drug use in the post-pandemic era.